Back to Journals » OncoTargets and Therapy

SJR OA
CiteScore
Impact Factor

OncoTargets and Therapy

ISSN: 1178-6930


       

Editor-in-Chief: Professor Gaetano Romano

OncoTargets and Therapy is an international, peer-reviewed journal focusing on the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. This journal explores the evidence behind new and existing therapies to aid their informed acceptance by clinicians and treatment adherence by patients.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Articles:

Latest articles:

- 5 records -

Original Research

Lidocaine as a Potential Therapeutic Agent in Colorectal Cancer: A Study of Gene Expression and Prognosis

Li W, Gao W, Lu C, Ji M, Yin Y, Zhang H, Liu C, Yu C

OncoTargets and Therapy 2025, 18:737-749

Published Date: 18 June 2025

Original Research

IGFBP1 is One of 10 Metabolic Factors Predicting Recurrence Free Survival in Gastric Cancer and Promotes Cancer Progression via ZFX-IGFBP1 Axis

Liu H, Huang Y, Fu G, Lei B, Liu K

OncoTargets and Therapy 2025, 18:717-732

Published Date: 5 June 2025

Method

Studying Immunogenic Cell Death in Human Colorectal Cancer Organoids

Lisandrelli R, Winkler M, Trajanoski Z, Lamberti G

OncoTargets and Therapy 2025, 18:705-715

Published Date: 6 June 2025

Original Research

Lowering the Selinexor Dose within the Pomalidomide and Dexamethasone Combination Regimen Elicits Fewer Side Effects While Comparable Efficacy Against Relapsed/Refractory Multiple Myeloma

Peng L, Shan T, Zhou X, Feng Z, Qiang W, Lu J, He H, Du J

OncoTargets and Therapy 2025, 18:695-703

Published Date: 6 June 2025

Original Research

MAM Domain Containing 2 (MAMDC2) Affects Invasion and Metastasis of Human Gastric Cancer

Shen J, Gao G, Liu S

OncoTargets and Therapy 2025, 18:679-693

Published Date: 26 May 2025


Read more articles